COVID-19 vaccination - summary for immunisation providers For health professionals Main navigation Australian Immunisation Handbook COVID-19 vaccines Immunisation coverage data and reports Education and training History of immunisation Immunisation schedules National and international resources NCIRS fact sheets, FAQs and other resources NCIRS webinar series Patient communication resources Specialist immunisation services SKAI - supporting health professionals NCIRS newsletters Vaccine safety The Australian Government Department of Health and Aged Care website now has a dedicated page for Clinical guidance for COVID-19 vaccine providers. This page has the latest updates from the Australian Technical Advisory Group on Immunisation (ATAGI), clinical information, COVID-19 vaccines doses and recommendations, vaccine efficacy and effectiveness, and additional clinical considerations. Additional information is provided below (Last updated: 16 December 2022): COVID-19 vaccine safety surveillance AusVaxSafety AusVaxSafety is conducting comprehensive active safety monitoring of all COVID-19 vaccines being used in Australia. The latest safety surveillance data report on adverse events following COVID-19 vaccination for all participants, including Aboriginal and Torres Strait Islander people. Over 6.3 million participants have responded to surveys, with 44.4% reporting an adverse event following COVID-19 vaccination. Most common adverse events include injection site pain, fatigue, headache and other expected side effects following immunisation. Related resource: AusVaxSafety COVID-19 vaccine safety surveillance Therapeutic Goods Administration The TGA is closely monitoring suspected adverse events following vaccination with COVID-19 vaccines in use in Australia. The latest weekly safety report of the TGA provides detailed information about the reported side effects for COVID-19 vaccines, total adverse event reports, reporting rates per 1000 doses by jurisdiction, and most commonly reported vaccine side effects. The most frequently reported suspected side effects continue to be events that were seen in the clinical trials and are commonly experienced with vaccines generally. Related resource: TGA COVID-19 vaccine safety weekly report Variants of concern World Health Organization tracker The World Health Organization (WHO) is tracking SARS-CoV-2 variants Related resource: WHO Variants of concern Answering patients' questions and concerns about COVID-19 vaccines Common questions answered NCIRS COVID-19: Frequently asked questions This webpage is updated regularly with new questions and answers, and advice as it becomes available. NCIRS COVID-19 and children: Frequently asked questions This newly developed webpage answers questions about COVID-19 vaccines for children, vaccine safety and effectiveness, and schooling. Decision aid (16+ years): Should I get the COVID-19 vaccine? This decision aid is designed to help you decide, in five simple steps, whether COVID-19 vaccination is right for you. Decision aid (5–15 years): Should I get the COVID-19 vaccine for my child? This decision aid is designed to help you decide, in five simple steps, whether COVID-19 vaccination is right for your child. COVID-19 vaccines – Is it true? This resource from the Department of Health answers common questions on COVID-19 vaccines and is available in 63 languages. VaxFACTS This resource from the University of Melbourne provides answers to some key questions about COVID‑19 vaccines and vaccination in short video clips. Case numbers and statistics Case numbers Coronavirus (COVID-19) case numbers and statistics (Australian Government Department of Health and Aged Care) News & events All news & events 21 September 2023 | News Multiple vaccinations for children – new NCIRS resource 31 August 2023 | News PAEDS network provides crucial data on Strep A infections in Australia 10 July 2023 | News Immunisation for individuals with additional needs – Practical guide 20 June 2023 | News New Vaccination for Our Mob virtual report available now 44702 views